Clinical Trials on Medial Malleolus Fracture in Canada

Total 4251 results

Boehringer Ingelheim

Completed

BI 409306 in Patients With Cognitive Impairment Due to Alzheimer's Disease.

Alzheimer Disease

United States, Canada, United Kingdom, Germany, Portugal, France, Belgium, Netherlands, Austria, Poland, Italy
Celgene

Completed

Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors

Melanoma | Sarcoma, Soft Tissue | Cancer | Fibrosarcoma | Neuroblastoma | Osteogenic Sarcoma | Rhabdomyosarcoma | Neoplasm | Malignant Melanoma | Tumors | Histiocytoma | Dermatofibrosarcoma | Sarcoma, Ewing's | Neoplasia | Ewing's Sarcoma | Ewing's Tumor | Sarcomas, Epitheliod | Sarcoma, Spindle Cell | Clinical Oncology | Oncology,... and other conditions

United States, Canada, Spain, France, United Kingdom, Italy, Switzerland
OPKO Health, Inc.

Completed

ELND005 in Patients With Mild to Moderate Alzheimer's Disease

Alzheimer Disease

United States, Canada
Bayer

Completed

Evaluation of Bay 59-8862 in Patients With Aggressive, Refractory Non-Hodgkin's Lymphoma

Lymphoma, Non-Hodgkin

Canada, France, Germany, United States, Netherlands, United Kingdom
University of Southern California
National Institute on Aging (NIA); Northern California Institute of Research... and other collaborators

Recruiting

Alzheimer's Disease Neuroimaging Initiative 4 (ADNI4)

Dementia | Alzheimer Disease | Mild Cognitive Impairment

United States, Canada
Baxalta now part of Shire
Alzheimer's Disease Cooperative Study (ADCS)

Completed

A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s Disease

Alzheimer´s Disease

United States, Canada
Hoffmann-La Roche

Completed

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

Germany, Mexico, Poland, Spain, United States, France, Canada, Italy, Slovakia, Argentina, Australia, United Kingdom, Romania
Bristol-Myers Squibb

Terminated

A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease

Alzheimer's Disease

Sweden, United States, Canada, Denmark, France, Finland
Hoffmann-La Roche

Completed

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment

Major Depressive Disorder

United States, Germany, Austria, Russian Federation, Ukraine, Canada, Slovakia, South Africa
Janssen Research & Development, LLC

Recruiting

A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI) (VENTURA-RWE)

Depressive Disorder, Major

United States, Korea, Republic of, Brazil, Spain, Argentina, United Kingdom, Sweden, Italy, Germany, France, Canada
Pfizer

Completed

An 8 Week Study Looking At The Efficacy, Toleration And Safety Of SS-RBX For Stress Urinary Incontinence.

Urinary Incontinence, Stress

United States, Canada
Novartis Pharmaceuticals

Completed

Evaluating Use of Deferasirox as Compared to Deferoxamine in Treating Cardiac Iron Overload (CORDELIA)

Transfusional Hemosiderosis | Transfusional Iron Overload

Taiwan, Turkey, Egypt, United Kingdom, Thailand, Canada, China, Italy, Cyprus, Lebanon, United Arab Emirates
GlaxoSmithKline

Completed

Effects Of GW679769 On Sleep Onset And Maintenance And Next Day Functioning In Subjects With Primary Insomnia

Insomnia | Sleep Initiation and Maintenance Disorders

United States, Canada
Bausch Health Americas, Inc.
Progenics Pharmaceuticals, Inc.

Completed

Study Evaluating Subcutaneous Methylnaltrexone For Treatment Of Opioid-Induced Constipation In Patients With Advanced Illness

Opioid-Induced Constipation

United States, Australia, Belgium, Canada, France, Germany, Italy, Mexico, United Kingdom, Brazil, Spain, Sweden
Pfizer

Completed

Relapse Prevention Study Of Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive Disorder

Major Depressive Disorder

Canada, United States, Colombia, Croatia, Estonia, Finland, Poland, France, Slovakia, Chile, Latvia, Lithuania, Romania, South Africa
Boehringer Ingelheim

Completed

A Study to Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With Depression

Depressive Disorder, Major

Spain, United States, Canada, Germany, Japan, Argentina, Hungary, France, Australia, Bulgaria, Czechia, Poland, Russian Federation, Slovakia
AstraZeneca

Completed

Predictors of Recurrence in Bipolar Disorder in Spain (PREBIS)

Bipolar Disorder

Spain
Otsuka Pharmaceutical Development & Commercialization...
H. Lundbeck A/S

Completed

Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type

Nervous System Diseases | Alzheimer's Disease | Mental Disorder | Agitation Associated With | Alzheimer's Type

France, United States, Bulgaria, Slovenia, United Kingdom, Russian Federation, Ukraine, Finland, Canada
Hoffmann-La Roche

Completed

A Study of RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25305)

Schizophrenia

United States, China, Italy, Bulgaria, Russian Federation, Japan, Czech Republic
Carelon Research
National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...

Completed

Congenital Heart Disease: Impact on Learning and Development in Down Syndrome (CHILD-DS) (CHILD-DS)

Down Syndrome | Congenital Heart Disease

United States, Canada
Northwell Health
National Institute of Mental Health (NIMH); University of California, Los Angeles and other collaborators

Completed

An Integrated Program for the Treatment of First Episode of Psychosis (RAISE ETP)

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder | Psychotic Disorder NOS | Brief Psychotic Disorder

United States
Bayer

Completed

Study to Compare the Tolerability and Efficacy of Once Daily Vardenafil vs Vardenafil PRN vs Placebo in Men Immediately After Nerve-sparing Prostatectomy for Improving ED

Erectile Dysfunction | Sexual Dysfunction, Physiological

Belgium, Italy, Spain, France, Switzerland, Canada, Sweden, Austria, United States, Germany, United Kingdom, South Africa, Netherlands, Norway, Finland
Forest Laboratories
Gedeon Richter Ltd.

Completed

Safety, Tolerability, and Efficacy of Cariprazine in Participants With Bipolar Depression

Depression, Bipolar

United States, Ukraine, Bulgaria, Canada, Colombia, Russian Federation
Hoffmann-La Roche

Completed

APPROACH Study: Quality of Life and Outcomes Assessment in Participants With Chronic Hepatitis C (CHC) Treated With Pegylated Interferon (PEG-IFN) Alfa-2a and Ribavirin

Hepatitis C, Chronic

Canada
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Lecozotan SR in Mild to Moderate Alzheimer's Disease (AD)

Alzheimer Disease

United States, Canada, South Africa, Argentina, Australia
Voyager Pharmaceutical Corporation

Completed

ALADDIN Study - Phase III: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (VP-AD-301)

Alzheimer's Disease

United States, Canada
H. Lundbeck A/S

Completed

Real-life Effectiveness of Vortioxetine in Depression (RELIEVE)

Major Depressive Disorder

United States, Canada, France, Italy
Pfizer

Completed

Study To Evaluate Cardiac Assessments Following Different Treatments Of Smoking Cessation Medications In Subjects With And Without Psychiatric Disorders. (CATS)

Smoking Cessation

United States, Spain, Germany, Canada, South Africa, Finland, Denmark, Australia, Argentina, Brazil, Bulgaria, Chile, Mexico, New Zealand, Russian Federation, Slovakia
Idorsia Pharmaceuticals Ltd.

Completed

Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep

Insomnia Disorder

United States, Korea, Republic of, Germany, Belgium, Bulgaria, Canada, Czechia, Finland, France, Hungary, Sweden
Hoffmann-La Roche

Terminated

An Open-Label Crenezumab Study in Participants With Alzheimer's Disease (CREAD OLE)

Alzheimer's Disease

United States, Korea, Republic of, United Kingdom, Canada, Poland, Australia, Russian Federation, Spain, Germany, Mexico, Finland, Italy, Turkey, Hong Kong, Lithuania, France
Bellus Health Inc

Unknown

Evaluation of 3APS in Patients With Mild to Moderate Alzheimer's Disease

Alzheimer Disease

Canada, United States
Instituto de Mayores y Servicios Sociales (IMSERSO)
University of Castilla-La Mancha; Confederación Española de Alzheimer (CEAFA)

Active, not recruiting

Effectiveness and Cost-Effectiveness of Cognitive Stimulation Therapy - Spain (CST-ES) in People Living With Dementia

Neurocognitive Disorders | Dementia | Mild Cognitive Impairment

Spain
University of Milano Bicocca

Recruiting

International CIPN Assessment and Validation Study (ICAVS)

Quality of Life | Chemotherapy-induced Peripheral Neuropathy

United States, Italy, France, Australia, Austria, Bangladesh, Brazil, Canada, Denmark, Germany, Greece, Kenya, Korea, Republic of, Portugal, Spain, Switzerland
EndoCeutics Inc.

Completed

Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)

Hypoactive Sexual Desire Disorder

United States, Canada
Takeda

Completed

Vortioxetine (Lu AA21004) 10 and 20 mg for Treatment of Major Depressive Disorder With Sexual Dysfunction

Treatment Outcome

United States, Canada
Cephalon

Completed

Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy

Narcolepsy

United States, Canada
H. Lundbeck A/S
Takeda

Completed

Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Participants Aged 7 to 11 Years With Major Depressive Disorder (MDD)

Depressive Disorder, Major

Korea, Republic of, United States, Hungary, Poland, Spain, Serbia, Estonia, Bulgaria, Mexico, Russian Federation, Ukraine, Canada, Colombia, France, Germany, Israel, Italy, Latvia, South Africa
H. Lundbeck A/S
Takeda

Completed

Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD)

Depressive Disorder, Major

United States, Bulgaria, Canada, Colombia, Estonia, France, Germany, Hungary, Italy, Korea, Republic of, Latvia, Mexico, Poland, Russian Federation, Serbia, South Africa, Spain, Ukraine, United Kingdom
Eli Lilly and Company

Completed

A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease

Alzheimer Disease (AD)

United States, Canada, Japan
Sumitomo Pharma America, Inc.

Terminated

A Clinical Study of an Investigational Drug for the Treatment of Major Depressive Episode Associated With Bipolar I Disorder.

Depressive Episodes, Bipolar I Depression

United States, Bulgaria, Japan, Romania, Canada, Slovakia
AbbVie

Completed

The Objective of This Study is to Evaluate the Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone

Major Depressive Disorder

United States, Canada, Czechia, Finland, Poland, Puerto Rico, Serbia, Slovakia
Vaccinex Inc.
Huntington Study Group

Completed

A Study in Subjects With Late Prodromal & Early Manifest HD to Assess the Safety, Tolerability, pk, and Efficacy of Pepi (SIGNAL-HD)

Huntington's Disease

United States, Canada
Hoffmann-La Roche

Completed

A Study to Evaluate Efficacy and Safety of Bitopertin in Participants With Persistent, Predominant Negative Symptoms of Schizophrenia

Schizophrenia

United States, Italy, China, Japan, Russian Federation, Bulgaria, Czech Republic
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Combination of Levonorgestrel (LNG) and Ethinyl Estradiol (EE) in Premenstrual Dysphoric Disorder

Menstruation Disturbances | Premenstrual Syndrome

United States, Canada
Pfizer

Completed

A Randomized, Double Blind, Parallel Group, Placebo Controlled, Multicenter Outpatient Trial Of PD 0200390 In Adults With Primary Insomnia

Insomnia

United States, Canada
NCIC Clinical Trials Group

Completed

Radiation Therapy to Relieve Symptoms in Patients With Non-small Cell Lung Cancer

Quality of Life | Pain | Fatigue | Lung Cancer | Pulmonary Complications | Nausea and Vomiting

Canada
Instituto Grifols, S.A.
Grifols Biologicals, LLC

Completed

A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease (AMBAR)

Alzheimer's Disease

Spain, United States
AstraZeneca

Completed

Proof of Concept Study of Cognitive Improvement in Patients With Alzheimer's Disease (Sirocco)

Alzheimer Disease

Bulgaria, Czech Republic, Russian Federation, United Kingdom, Germany, Romania, Canada, Austria, Belgium, Spain
Washington University School of Medicine
National Institute on Aging (NIA); Alzheimer's Association; Eisai Inc.; Accelerating...

Active, not recruiting

Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU) (DIAN-TU)

Dementia | Alzheimers Disease | Alzheimers Disease, Familial

United States, Canada, Italy, France, Spain, Brazil, Ireland, Japan, Argentina, Australia, Colombia, Germany, Mexico, Netherlands, Puerto Rico, United Kingdom
Otsuka Pharmaceutical Development & Commercialization...

Completed

Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia (ZENITH)

Schizophrenia

Korea, Republic of, United States, Philippines, Malaysia, Croatia, Serbia, Russian Federation, Ukraine, Romania, Puerto Rico, Colombia, Turkey, Poland, Taiwan, Canada, Latvia, Slovakia, Mexico, Japan

Clinical Trials on Medial Malleolus Fracture in Canada

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Equatorial Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations